Crosslinked Hyaluronic Acid With Liposomes and Crocin in Dry Eye
NCT03617315 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25
Last updated 2018-08-14
Summary
A total of 50 eyes were analyzed (25 patients). The subjects selected were over 18 years of age. No gender distinction was made in the choice of subjects. All subjects were carriers of silicone hydrogel contact lenses. The antecedents of the eye diseases not identified, neither the previous eye surgeries nor the systemic or ocular medication. All patients read, understood and signed an informed consent form of the study.
Conditions
- Dry Eye
- Meibomian Gland Dysfunction
- Dry Eye Syndromes
Interventions
- DRUG
-
Hylauronic Acid
Schirmer Test, BUT test and OSDI test. Previous and After treatment
Sponsors & Collaborators
-
University of Seville
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 30 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-10-01
- Primary Completion
- 2018-02-01
- Completion
- 2018-03-20
Countries
- Spain
Study Locations
More Related Trials
-
Trial of CF101 to Treat Patients With Dry Eye Disease
NCT01235234 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Dry Eye Syndrome With Cyclosporin A Eye Drops
NCT00001731 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Ocular Lubricant Eyedrops on Lid Parallel Conjunctival Folds and Other Signs and Symptoms of Dry Eye
NCT01268735 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Cyclosporine Ophthalmic Soution Group and Cyclosporine Ophthalmic Suspension Group
NCT01768312 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of a Multiple-Action Tear Substitute (TriMix) in Dry Eye Disease
NCT06478134 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Evaluating HA 0.15% Compared With Cyclosporine 0.05%, and Efficacy of Combination Therapy in Dry Eye Disease Patients
NCT04127851 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Topical Hydrocortisone on Signs and Symptoms of Dry Eye Associated to Meibomian Gland Dysfunction
NCT05159284 ·Status: RECRUITING ·Phase: PHASE4
-
Safety Study of the Use of Topical Cyclosporine in the Treatment of Dry Eye Disease
NCT02004067 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy Study of CF101 to Treat Keratoconjunctivitis Sicca
NCT00349466 ·Status: COMPLETED ·Phase: PHASE2
-
Investigation of Preservative-Free Ophthalmic Solution in Ocular Dryness
NCT05778942 ·Status: COMPLETED
-
Comparison of Efficacy, Safety and Anti-Inflammatory Effect Between Topical 0.05%Cyclosporine A Emulsion and REFRESH® in Patients With Moderate to Severe Dry Eyes
NCT00704275 ·Status: UNKNOWN ·Phase: PHASE4
-
A Prospective, Randomized, Placebo and Active Comparator Controlled Study of CP-690,550 in Subjects With Dry Eye.
NCT00784719 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effects of RP101 in Post-menopausal Women With Dry Eye Syndrome
NCT03821415 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Tolerability, Plug Retention and Preliminary Efficacy of Tacrolimus-loaded Punctal Plug in Patients With Moderate to Severe Dry Eye Disease - Cohort B
NCT05618730 ·Status: UNKNOWN ·Phase: PHASE1
-
The Effects of a Single Intravenous Administration of Secukinumab (AIN457) or Canakinumab (ACZ885) in Dry Eye Patients
NCT01250171 ·Status: COMPLETED ·Phase: PHASE2
-
Levocarnitine for Dry Eye in Sjogren's Syndrome
NCT03953703 ·Status: COMPLETED ·Phase: PHASE2
-
Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye Syndrome
NCT00025818 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Confirm the Efficacy and Safety of K-161 Ophthalmic Solution for Treatment of Moderate to Severe Dry Eye Disease
NCT05403827 ·Status: COMPLETED ·Phase: PHASE3
-
Study on Prevention and Treatment of Dry Eye in Patients Using Glaucoma Drops
NCT03515187 ·Status: UNKNOWN ·Phase: PHASE3
-
Tolerability, Safety and Efficacy of Lubricin Versus Sodium Hyaluronate Eye Drops in Patients With Moderate Dry Eye
NCT02507934 ·Status: COMPLETED ·Phase: NA
-
Safety, Tolerability and Systemic Pharmacokinetics of AGN-232411 in Healthy Participants and Participants With Dry Eye
NCT02420730 ·Status: COMPLETED ·Phase: PHASE1
-
Liposomal Sirolimus in Dry Eye Disease
NCT04115800 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Study Evaluating the Efficacy and Safety of RCI001 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye
NCT07068958 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Study Evaluating HBM9036 Efficacy and Safety on Moderate to Severe Dry Eye
NCT04633213 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
NCT02188160 ·Status: COMPLETED ·Phase: PHASE2